Use of Plasma Brain Natriuretic Peptide Concentration to Aid the Diagnosis of Heart Failure

Shapiro, Brian P.; Chen, Horng H.; Burnett Jr., John C.; Redfield, Margaret M.
April 2003
Mayo Clinic Proceedings;Apr2003, Vol. 78 Issue 4, p481
Academic Journal
Examines the use of plasma brain natriuretic peptide (BNP) concentration to aid in the diagnosis of heart failure. Appropriate time to order this test; Physiology of BNP; Clinical evidence of the diagnostic ability of BNP; BNP level that indicates heart failure.


Related Articles

  • Natriuretic peptide test for heart failure. Fuat, Ahmet // GP: General Practitioner;9/22/2003, p59 

    Heart failure is an increasing problem. It is mostly managed by general practitioner (GP), but the diagnosis of patients with breathlessness is often difficult, and an accurate diagnosis of heart failure is essential before starting treatment. Since echocardiography first arrived in the 1970s,...

  • Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence. S Dhar // Postgraduate Medical Journal;Jun2009, Vol. 85 Issue 1004, p299 

    Natriuretic peptides such as brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) are commonly used in the diagnosis and evaluation of heart failure. However, their utility in patients with chronic kidney disease (CKD) is less clear as renal dysfunction itself can be associated...

  • Should All Heart Failure Patients Undergo Echocardiographic Examination? Kolo, P. M.; Omotoso, A. B. O. // Internet Journal of Cardiology;2010, Vol. 9 Issue 2, p1 

    The recent advances in the management of chronic heart failure (CHF) have the potentials to delay the onset or slow down its progression, improve symptoms and quality of life with better clinical outcome. Early detection of CHF is very crucial for effective intervention but the diagnosis of mild...

  • Testing for BNP in heart failure patients.  // New Zealand Doctor;6/14/2006, p28 

    Emphasizes the importance of testing heart failure (HF) patients for B-type natriuretic peptide (BNP). Information on how BNP is secreted by the body; Effect of BNP testing on the hospital stay of HF patients; Results of several studies concerning BNP.

  • Clinical practice: Brain-type natriuretic peptide. Kant, Sabby // Update;Feb2007, Vol. 74 Issue 2, p77 

    The article focuses on a test involving measuring the levels of brain-type natriuretic peptide (BNP) for the diagnosis of heart failure. BNP is an atrial peptide secreted by the heart whenever its ventricles are under tension. Use of the test has resulted in significant cost savings by...

  • Can heart failure be diagnosed in primary care? Hobbs, Richard // BMJ: British Medical Journal (International Edition);07/22/2000, Vol. 321 Issue 7255, p188 

    Editorial. Discusses the importance of accurate and early diagnosis of symptomatic heart failure and its impact on patients and healthcare systems. Difficulties involved in the accurate diagnosis of heart failure; Alternatives to echocardiography in primary care; Potential diagnostic aids,...

  • BNP and NT-proBNP Assays for Heart-Failure Diagnosis in Patients With Cerebral Infarction. Xiuming Zhang; Weijia Wang; Yuanlong Yu; Qian Wang; Youye Yang; Dongmei Wen; Fei Li; Nengliang Ouyang; Lijuan Kan; Minghuan Suo; Haizhong Yan // Laboratory Medicine;Winter2013, Vol. 44 Issue 1, p46 

    Objective: To determine whether BNP or NT-proBNP levels more strongly indicate or predict cardiac diseases in patients with chronic heart failure, cerebral infarction, cerebral hemorrhage, and acute cerebral infarction complicated with heart failure. Methods: A total of 303 patients aged 33 to...

  • Plasma N-terminal pro-B-type natriuretic peptide: selecting the optimal heart failure marker in children of age up to 18 years. Menghong Deng; Chunwang Lin; Wen Tang; Huayong Zhu; Yi Zhang // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 10, p10756 

    Background: The cutoff values of plasma N-terminal-pro-B-type natriuretic peptide (NT-proBNP) for the heart failure (HF) is vague in children. We determined the NT-proBNP levels that indicated HF in age-stratified groups of children up to age 18. Methods: This is a prospective clinical study and...

  • Editorial [ Neuropeptide Y Receptors as Targets in Drug Discovery Guest Editor: Ambikaipakan Balasubramaniam ]. Balasubramaniam, Ambikaipakan // Current Topics in Medicinal Chemistry;Sep2007, Vol. 7 Issue 17, p1644 

    My daughter was borne in 1980, surely a good omen! At about the same time, I joined the University of Cincinnati as a fellow, and was looking for a new project in the GI hormone field and, coincidentally Tatemoto, the Man with Gold Fingers, added neuropeptide Y (NPY) and peptide YY (PYY) to his...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics